JC virus detection and JC virus-specific immunity in natalizumab-treated Multiple Sclerosis patients
<p>Abstract</p> <p>Background</p> <p>The use of natalizumab in multiple sclerosis (MS) may favour JC virus reactivation; this phenomenon is usually asymptomatic but can, albeit rarely, evolve into frank progressive multifocal leucoencephalopathy (PML).</p> <p>Methods</p> <p>JCV-specific CD8+ T lymph...
Furkejuvvon:
| Váldodahkkit: | , , , , , , , , |
|---|---|
| Materiálatiipa: | Artigo |
| Giella: | Inglês |
| Almmustuhtton: |
BMC
2012-12-01
|
| Ráidu: | Journal of Translational Medicine |
| Fáttát: | |
| Liŋkkat: | http://www.translational-medicine.com/content/10/1/248 |
| Fáddágilkorat: |
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|